End­points In­sid­er: The world’s old­est new biotech pub ends its 12th month on a roll

We’ve been watch­ing our web traf­fic grow month-to-month at a dou­ble-dig­it pace. In June, traf­fic at End­points News hit 313,439, ex­act­ly 10% high­er than the month be­fore, with 161,226 unique vis­i­tors to the site. And our sub­scriber list broke the 16,000 mark – heav­i­ly con­cen­trat­ed among bio­phar­ma ex­ec­u­tives — as we head straight to 20,000 this fall.

I like to say that End­points is the old­est new bio­phar­ma pub on the block. For those of you who have fol­lowed me over the past 15 years – in­clud­ing much of the 14 years be­fore Ar­salan Arif and I part­nered on the launch on June 20, 2016 – it’s that track record and abil­i­ty to swift­ly add con­text to the news that makes this pub dif­fer­ent from all of the rest. And as we grow the staff this sum­mer, you can bet that we’ll be look­ing to con­tin­ue to broad­en our cov­er­age base and ge­o­graph­ic reach as we look to grow the au­di­ence and web traf­fic to 500,000-plus in the near fu­ture.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.